AXIM BIOTECHNOLOGIES, INC. Note Agreements
13 Contracts & Agreements
- Form of Version 3 Note dated March 15, 2024 (Filed With SEC on March 21, 2024)
- Form of Version 2 Note dated March 15, 2024 (Filed With SEC on March 21, 2024)
- Form of Version 1 Note dated March 15, 2024 (Filed With SEC on March 21, 2024)
- Form of Convertible Note Purchase Agreement dated March 15, 2024 (Filed With SEC on March 21, 2024)
- EXHIBIT A FORM OF NOTE (Filed With SEC on December 28, 2023)
- CONVERTIBLE NOTE PURCHASE AGREEMENT (Filed With SEC on December 28, 2023)
- CONVERTIBLE NOTE (Filed With SEC on May 30, 2023)
- Convertible Note Modification and Default Waiver Agreement (Filed With SEC on January 27, 2023)
- Convertible Notes Modification and Default Waiver Agreement (Filed With SEC on January 27, 2023)
- AXIM BIOTECHNOLOGIES, INC. 6% CONVERTIBLE REDEEMABLE NOTE DUE SEPTEMBER 29, 2022 (Filed With SEC on February 16, 2022)
- CONVERTIBLE NOTE (Filed With SEC on February 16, 2022)
- PROMISSORY NOTE (Filed With SEC on February 16, 2022)
- CONVERTIBLE PROMISSORY NOTE (Filed With SEC on December 7, 2018)
